Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_assertion type Assertion NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_head.
- NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_assertion description "[rIFN-alpha-induced GD is characterized by suppressed thyroid-stimulating hormone levels; normal or elevated free triiodothyronine (FT3) and free thyroxine (FT4) values; the presence of thyroid peroxidase antibodies, antithyroglobulin antibodies, and thyroid receptor antibodies; and high iodine thyroid uptake.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_provenance.
- NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_assertion evidence source_evidence_literature NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_provenance.
- NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_assertion SIO_000772 16025878 NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_provenance.
- NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_assertion wasDerivedFrom befree-20150227 NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_provenance.
- NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_assertion wasGeneratedBy ECO_0000203 NP756761.RAcXadcYRQJfD7DDqYevPVmonAzehyI6N6cUdxhbS6N8E130_provenance.